Document Ra917ko5G5JVDDg35Lwqzj8Y7

to COLUM BUS, OHIO OFFICE TW ELFTH FLOOR 21 E A ST STATE S T R E E T COLUM BUS, O HIO 43215*4221 614-221-2838 FAX: 614 -2 21 -2 0 07 Ro b er ta . Bilott (513) 357-9638 bilott@taftlaw.com TAFT, STETTIN IUS & HOLLISTER LLP 425 WALNUT STREET, SUITE 1800 CINCINNATI, OHIO 45202-3957 513-381-2838 FAX: 5 1 3 -3 8 1-0 2 0 5 www.taftiaw.com May 6, 2003 NORTHERN KENTUCKY OFFICE SUITE 340 1717 DIXIE HIGHW AY C O VIN GTON , KENTUC KY 4 10 11-4704 859-331-2838 513-381-2838 FAX: 5 1 3 -3 81 -6 6 13 CLEVELAND, O HIO O FFICE 3500 BP TOWER 200 PUBLIC SQUARE CLEVELAND, O HIO 44114-2302 216-241-2838 FAX: 216 -2 41 -3 7 07 Dr. Charles M. Auer Chemical Control Division Office of Prevention, Pesticides and Toxic Substances U.S. Environmental Protection Agency 1200 Pennsylvania Avenue, N.W. Mail Code 7405M Washington, DC 20004 TELECOPY Jennifer Seed U.S. Environmental Protection Agency 410 M Street, S.W. Washington, DC 20460 Christopher Jones, Esq. Director Ohio Environmental Protection Agency 122 South Front Street Columbus, OH 43215 Thomas V. Skinner Regional Administrator U.S. Environmental Protection Agency 77 West Jackson Blvd. Chicago, IL 60604 Oscar Hernandez Director, Risk Assessment Division Office of Prevention, Pesticides and Toxic Substances U.S. Environmental Protection Agency 1200 Pennsylvania Avenue, N.W. Mail Code 7405M Washington, DC 20460 John Wheeler, Ph.D. (E-29) ATSDR 1600 Clifton Road, N.E. Atlanta, GA 30333 Donald S. Welsh Regional Administrator U.S. Environmental Protection Agency Region UI 1650 Arch Street Philadelphia, PA 19103-2029 1*0 CCS OJ mC/O "O o^o -am cin ---oimo -o Ofm 3C o a F3 CD K0 Re: Human Health Threat Arising From Releases Of PFOA/APFO/C-8 In West Virginia And Ohio____________________________________ CONTAIN NO ORi OOOOOI May, 2003 Page 2 Ladies and Gentlemen: As a follow up to our letters of February 3, April 4, and April 11, 2003 regarding the potential health threat to those living near the Washington Works plant of E.I. duPont de Nemours and Company located in Wood County, West Virginia, we have enclosed copies of the following documents relating to the health condition of workers at that DuPont plant where C-8 has been used in manufacturing processes since the early 1950s: 1. DuPont Internal Report, "Study Of Myocardial Infarction At Washington Works Plant" (1975) (DUPONT910-918);i/ and 2. E.I. duPont de Nemours and Company's Objections And Response To Plaintiffs' Third Set Of Interrogatories And [Sixth] Set Of Requests For Production Of Documents (April 28, 2003).- RAB/mdm Enclosures cc: R. Edison Hill, Esq. (w/o ends.) Larry A. Winter, Esq. (w/o ends.) Gerald J. Rapien, Esq. (w/o ends.) Mary Dominiak, (USEPA, OPPT) (for inclusion in AR-226) (w/ ends.) (by telecopy and Federal Express) - As a Defendant in a class action lawsuit pending against DuPont in the West Virginia State Court in which we serve as Class counsel, DuPont has the right to mark documents produced in that case as falling under the terms of the Stipulated Protective Order that allows parties to limit distribution of documents, if they qualify as documents for which "confidential business information" (CBI), protection would be available under, among other provisions, 40 C.F.R. Part 2, Subpart B. Although DuPont originally marked this document as confidential under that Order, DuPont has since confirmed in writing that it has withdrawn its confidentiality claim with respect to this report. - Exhibit B to this set of DuPont's discovery responses has been removed, because the document has been marked "confidential" under the terms of the Stipulated Protective Order referenced above in Footnote 1. We are currently challenging DuPont's confidentiality claim with respect to that document but the issue has not yet been resolved. 000002